Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 44.30
+0.30 (0.68%)
At close: Feb 11, 2026
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.57 billion as of February 13, 2026. Its market cap has decreased by -21.39% in one year.
Market Cap
3.57B
Enterprise Value
2.84B
Revenue
792.49M
Ranking
n/a
PE Ratio
17.10
Stock Price
44.30
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.57B, an increase of 1.40%. That is a compound annual growth rate of 0.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.57B | 3.50% |
| Dec 31, 2025 | 3.45B | -20.87% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Optical Technology | 5.94B |
| Pacific Hospital Supply | 5.91B |
| St.Shine Optical | 5.65B |
| SciVision Biotech | 5.17B |
| Bionime | 3.76B |
| Nang Kuang Pharmaceutical | 3.74B |
| ICARES Medicus | 3.18B |
| Crystalvue Medical | 1.88B |